Profiel
Brent Meadows served as the Chief Business Officer at Medicenna Therapeutics Corp.
in 2023 and previously held the same position at OncoOne Research & Development GmbH.
He earned an MBA from Babson College and an undergraduate degree from the University of Richmond.
Eerdere bekende functies van Brent Meadows
Bedrijven | Functie | Einde |
---|---|---|
MEDICENNA THERAPEUTICS CORP. | Corporate Officer/Principal | 26-10-2023 |
OncoOne Research & Development GmbH
OncoOne Research & Development GmbH BiotechnologyHealth Technology OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria. | Corporate Officer/Principal | - |
Opleiding van Brent Meadows
Babson College | Masters Business Admin |
University of Richmond | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MEDICENNA THERAPEUTICS CORP. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
OncoOne Research & Development GmbH
OncoOne Research & Development GmbH BiotechnologyHealth Technology OncoOne Research & Development GmbH engages in the research in as well as the development, manufacturing, and commercialization of therapeutics, specifically in the field of oncology. It specializes in the development of drugs and novel therapeutics for the treatment of solid tumor cancers. The company was founded by Randolf Kerschbaumer, Michael Thiele, and Alexander Schinagl in June 2018 and is headquartered in Klosterneuburg, Austria. | Health Technology |